Showing results (201-210 of 217) with videos related to
Sort By:
Pageof 22
The Journal of Urology|December 27, 2022
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database ConsortiumKosuke Takemura, Vishal Navani, Matthew S Ernst, et al.European Urology|January 27, 2023
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell CarcinomaMatthew S Ernst, Vishal Navani, J Connor Wells, et al.Clinical Genitourinary Cancer|October 14, 2025
CABOSEQ 3-Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab- Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)Audreylie Lemelin, David Maj, Kosuke Takemura, et al.JAMA Network Open|June 10, 2022
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell CarcinomaVishal Navani, Matthew Ernst, J Connor Wells, et al.The Lancet. Oncology|February 16, 2015
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based studyJenny J Ko, Wanling Xie, Nils Kroeger, et al.Kidney Cancer (Clifton, Va.)|October 19, 2018
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)Steven M Yip, Jose M Ruiz Morales, Frede Donskov, et al.Clinical Genitourinary Cancer|December 3, 2014
Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database ConsortiumAndré P Fay, Wanling L Xie, Jae-Lyn Lee, et al.European Journal of Cancer (Oxford, England : 1990)|August 4, 2016
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumJose Manuel Ruiz-Morales, Marcin Swierkowski, J Connor Wells, et al.Clinical Genitourinary Cancer|December 3, 2014
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumChristos E Kyriakopoulos, Namita Chittoria, Toni K Choueiri, et al.Journal of Geriatric Oncology|March 6, 2021
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysisDaniel V Araujo, J Connor Wells, Aaron R Hansen, et al.Pageof 22